Gilead Abandons Orphan Drug Designation for COVID-19 Drug
March 25, 2020
Mari Serebrov
BioWorld
Axinn partner Chad Landmon was quoted in the BioWorld article, "Gilead Abandons Orphan Drug Designation for COVID-19 Drug."
Click here to access the article.